ROCHE Farmaceutica Quimica, LDA secures contract for Antineoplastic and immunomodulating agents - 2023/0491 - POLATUZUMAB VEDOTINA [30 MG; PO CONC SOL INJ; FRS]

Portugal, Aug. 29 -- Portugal based ROCHE Farmaceutica Quimica, LDA has secured contract from Unidade Local de Saude Santa Maria, E.P.E. for Antineoplastic and immunomodulating agents - 2023/0491 - POLATUZUMAB VEDOTINA [30 MG; PO CONC SOL INJ; FRS]. The value of the contract is worth 8734824 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....